Ballentine Partners’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-181
| Closed | -$87K | – | 364 |
|
|
2018
Q3 | $87K | Hold |
181
| – | – | ﹤0.01% | 346 |
|
|
2018
Q2 | $82K | Hold |
181
| – | – | ﹤0.01% | 331 |
|
|
2018
Q1 | $106K | Hold |
181
| – | – | 0.01% | 341 |
|
|
2017
Q4 | $113K | Hold |
181
| – | – | 0.01% | 350 |
|
|
2017
Q3 | $167K | Hold |
181
| – | – | 0.01% | 360 |
|
|
2017
Q2 | $162K | Buy |
+181
| New | +$162K | 0.01% | 357 |
|
|
2013
Q3 | – | Sell |
-146
| Closed | -$46K | – | 140 |
|
|
2013
Q2 | $46K | Buy |
+146
| New | +$46K | 0.01% | 126 |
|